Back

Evidence for a Causal Pathway Between Socioeconomic Status and Melanoma in Situ

Dube, U.; Lin, J. Y.

2025-04-25 dermatology
10.1101/2025.04.23.25326166 medRxiv
Show abstract

Structured AbstractO_ST_ABSImportanceC_ST_ABSThe genetic architecture of disease risk may not be independent of social determinants. This can be leveraged to investigate for causality. ObjectiveTo investigate for a possible causal relationship between socioeconomic status (SES) and melanoma in situ (MIS) based on their genetic architectures. DesignGenetic correlation study SettingMulticenter and population-based data sources. ParticipantsThe Ingold et al., 2024 GWAS summary statistic dataset is derived from 3,564 MIS cases, 10,552 invasive melanoma (MM) cases, and 1,022,070 melanoma-free controls. Individuals with both MIS and MM were only included as MM cases. The Kweon et al., GWAS summary statistic dataset on income, a proxy for SES, is derived from an effective sample size of 668,288 individuals. Main Outcome(s) and Measure(s)Genetic correlation between MIS, MM, and SES. ResultsWe obtained European genomic ancestries-based GWAS summary statistics for MIS (3,564 cases and 1,022,070 melanoma-free controls), MM (10,552 cases and 1,022,070 melanoma-free controls), and SES (668,288 individuals). We identify a positive and significant genetic correlation between MIS and SES (0.14, 95% CI 0.06 to 0.21; p = 5.55 x 10-04) but not MM and SES (0.05, 95% CI -0.01 to 0.11; p = 0.11). The genetic architecture of MIS subtracting that of MM (MIS-MM) remained positively and significantly correlated with the genetic architecture of SES (0.23, 95% CI 0.07 to 0.39; p = 4.18 x 10-03). In contrast, the genetic architecture of MM subtracting that of MIS (MM-MIS) is negatively correlated with the genetic architecture of SES (-0.24, 95% CI -0.42 to -0.06; p = 8.01 x 10-03). Finally, taking a Mendelian Randomization approach, we identify consistent evidence for a causal pathway between MIS and SES but not MM and SES. Conclusions and RelevanceThe genetic architecture of SES correlates with that of MIS but not MM. There is also evidence for a causal link between SES and MIS. Both these findings support an overdiagnosis of MIS. Importantly, our results demonstrate genetic risk scores for disease are not inherently independent of social determinants of diagnosis. Clinical application of genetics-based risk stratification without consideration of social determinants may have limited utility. Key PointsO_ST_ABSQuestionC_ST_ABSIs socioeconomic status genetically correlated with melanoma in situ and is there any evidence for a causal relationship? FindingsIn this genetic correlation study based on data from 3,564 melanoma in situ cases, 10,552 invasive melanoma cases, 1,022,070 melanoma-free controls, and 668,288 individuals with income data; we identify a positive and significant genetic correlation between socioeconomic status and melanoma in situ but not invasive melanoma. We also identify Mendelian Randomization-based evidence for a causal relationship between socioeconomic status and melanoma in situ but not invasive melanoma MeaningThe genetic architecture of disease risk is not independent of social determinants of diagnosis. Clinical application of genetics-based risk stratification without consideration of social determinants may have limited utility.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
18.1%
2
European Journal of Cancer
11 papers in training set
Top 0.1%
7.7%
3
Journal of Investigative Dermatology
49 papers in training set
Top 0.1%
6.6%
4
British Journal of Dermatology
11 papers in training set
Top 0.1%
6.6%
5
Nature Communications
5641 papers in training set
Top 26%
6.1%
6
eClinicalMedicine
77 papers in training set
Top 0.1%
5.3%
50% of probability mass above
7
JAMA Network Open
130 papers in training set
Top 0.6%
5.3%
8
The American Journal of Human Genetics
234 papers in training set
Top 0.9%
5.3%
9
Nature Medicine
125 papers in training set
Top 0.4%
5.0%
10
BMC Cancer
67 papers in training set
Top 0.6%
3.3%
11
Journal of Medical Genetics
29 papers in training set
Top 0.2%
2.4%
12
Nature Genetics
286 papers in training set
Top 3%
2.3%
13
Scientific Reports
3612 papers in training set
Top 45%
2.3%
14
Experimental Dermatology
10 papers in training set
Top 0.1%
2.3%
15
Human Genomics
21 papers in training set
Top 0.1%
2.1%
16
Annals of Oncology
14 papers in training set
Top 0.1%
1.7%
17
JNCI: Journal of the National Cancer Institute
19 papers in training set
Top 0.2%
1.5%
18
Blood Advances
62 papers in training set
Top 0.8%
1.4%
19
BMC Medical Genomics
50 papers in training set
Top 0.7%
1.3%
20
JID Innovations
11 papers in training set
Top 0.2%
1.1%
21
eLife
5828 papers in training set
Top 61%
1.0%
22
npj Genomic Medicine
36 papers in training set
Top 0.9%
0.8%
23
International Journal of Cancer
49 papers in training set
Top 1%
0.6%
24
British Journal of Cancer
49 papers in training set
Top 2%
0.6%
25
Communications Biology
993 papers in training set
Top 37%
0.6%